hVDAC1蛋白在大肠杆菌中的表达纯化及其结构功能的初步表征

南京大学学报(自然科学版) ›› 2016, Vol. 52 ›› Issue (4): 609–.

hVDAC1蛋白在大肠杆菌中的表达纯化及其结构功能的初步表征

吕万胜^1，2，朱伶俐^1，2，吴先登¹，王泽南¹，郭文洁³，高　静³，华子春^1，2*，郑伟娟^1，2*

出版日期:2016-07-23 发布日期:2016-07-23
作者简介: 1.南京大学生命科学学院，南京，210023；2.医药生物技术国家重点实验室，南京，210023；3．江苏大学药学院，镇江，212013
基金资助:

基金项目：国家自然科学基金(81072712，81373400)，江苏省自然科学基金(BK2012710)，国家基础科学人才培养基金(J1103512，J1210026)

收稿日期：2015－06－10
*通讯联系人，Email：zchua@nju.edu.cn，wjzheng@nju.edu.cn

Expression，purification and characterization of hVDAC1 in E．coli

Lyu Wansheng^1，2，Zhu Lingli^1，2，Wu Xiandeng¹，Wang Ze’nan¹，Guo Wenjie³，Gao Jing³，Hua Zichun^1，2*，Zheng Weijuan^1，2*

Online:2016-07-23 Published:2016-07-23
About author: 1.School of Life Science，Nanjing University，Nanjing，210023，China；2．State Key Laboratory of Pharmaceutical Biotechnology，Nanjing，210023，China；3．School of Pharmacology，Jiangsu University，Zhenjiang，212013

摘要/Abstract

摘要： 电压依赖性阴离子通道蛋白(VDAC)是线粒体外膜上最丰富的蛋白，在调节线粒体的物质代谢与能量代谢、以及线粒体介导的细胞凋亡中起重要作用，因而与肿瘤及神经退行性疾病的发生密切相关．VDAC1是三种VDAC变体中表达量最高、分布最广泛的一种．由于VDAC1的高度保守性，因此成为多种疾病治疗包括抗肿瘤治疗的理想靶点．获得足量的VDAC1蛋白是进一步研究其结构功能、筛选与VDAC1相互作用的药物分子的基础．从生物样品中直接分离纯化VDAC1，不仅条件苛刻，而且得率很低．因此利用DNA重组技术在大肠杆菌中重组表达VDAC1是获得足量蛋白、用于后续研究的重要途径．成功构建了C端带有Histag的hVDAC1的重组蛋白原核表达质粒pET28a/hVDAC1，在大肠杆菌中以包涵体形式表达，并通过盐酸胍变性、在变性条件下通过NTANi亲和层析柱纯化蛋白后进行复性的方法，获得了高纯度的hVDAC1.圆二色谱检测显示该蛋白二级结构以β－折叠为主、符合hVDAC1的二级结构特征．利用流式细胞仪检测结果显示：FITC荧光标记的hVDAC1可以与脂质体膜、细胞膜特异性结合．证明克隆表达纯化的hVDAC1具有特征的膜蛋白结构和功能，为体外筛选与hVDAC1相互作用的各类分子奠定了基础．

Abstract: Voltagedependent anion channel(VDAC)is the most abundant protein found in the outer membrane of mitochondria，playing crucial roles not only in the regulation of metabolic and energetic functions of mitochondria，but also in mitochondriamediated apoptosis，thus involved in the development of certain diseases including cancer and neurodegenerative disorders.Among the three versions of VDAC which have been identified in mammals，VDAC1 is the one with the highest expression level and widely distribution in various tissues.The highly conservative property of VDAC1 makes it an excellent target for therapies of various diseases including anticancer intervention.Acquiring enough VDAC1 protein is the first step for further study of its structure and function relationship，as well as the screen of molecules interacting with VDAC1.Isolation of VDAC1 from various tissues encountered apparent contradictions，such as complicated purification processes and low yield.Therefore，expression and purification of recombinant VDAC1 in E．coli is a realistic approach to obtain large amount of protein for further research.In this study，recombinant protein hVDAC1，with Cterminal Histag，was expressed and purified from E．coli with high purity.The recombinant protein forms inclusion bodies when expressed in E．coli.After sonication and centrifugation，inclusion bodies were collected and denatured by high concentration guanidine hydrochloride.Purified by NTANi affinity chromatography and renatured by dialysis，hVDAC1 with high purity was obtained.The CD spectrum shows that the purified hVDAC1 adopts a similar folded conformation with high βsheet content，consistent with the previous studies.The specific binding of FITClabeled hVDAC1 to liposome or cell plasma membrane were confirmed by flow cytometry assay.These results show that the hVDAC1 protein we expressed and purified has the characteristic structure and function of membrane protein，and may provide a basis for further study.

吕万胜^1，2，朱伶俐^1，2，吴先登¹，王泽南¹，郭文洁³，高　静³，华子春^1，2*，郑伟娟^1，2*. hVDAC1蛋白在大肠杆菌中的表达纯化及其结构功能的初步表征[J]. 南京大学学报(自然科学版), 2016, 52(4): 609–.

Lyu Wansheng^1，2，Zhu Lingli^1，2，Wu Xiandeng¹，Wang Ze’nan¹，Guo Wenjie³，Gao Jing³，Hua Zichun^1，2*，Zheng Weijuan^1，2*. Expression，purification and characterization of hVDAC1 in E．coli[J]. Journal of Nanjing University(Natural Sciences), 2016, 52(4): 609–.

参考文献

[1]　Youle R J，Narendra D P．Mechanisms of mitophagy.Nature Reviews Molecular Cell Biology，2011，12(1)：9－14.
[2] Colombini M，Mannella C A．VDAC，the early days.Biochimica et Biophysica Acta，2012，1818(6)：1438－1443.
[3] ShoshanBarmatz V，De Pinto V，Zweckstetter M，et al.VDAC，a multifunctional mitochondrial protein regulating cell life and death.Molecular Aspects of Medicine，2010，31(3)：227－285.
[4] ShoshanBarmatz V，Golan M．Mitochondrial VDAC1：Function in cell life and death and a target for cancer therapy.Current Medicinal Chemistry，2012，19(5)：714－735.
[5] ShoshanBarmatz V，Mizrachi D．VDAC1：from structure to cancer therapy.Frontiers in Oncology，2012，2(164)．
[6] Reddy P H．Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer’s disease？Biochimica et Biophysica Acta，2013，1832(1)：67－75.
[7] Benz R．Permeation of hydrophilic solutes through mitochondrial outer membranes：Review on mitochondrial porins.Biochimica et Biophysica Acta，1994，1197(2)：167－196.
[8] Messina A，Reina S，Guarino F，et al.VDAC isoforms in mammals.Biochimica et Biophysica Acta，2012，1818(6)：1466－1476.
[9] Engelhardt H，Meins T，Poynor M，et al.Highlevel expression，refolding and probing the natural fold of the human voltagedependent anion channel isoforms Ⅰ and Ⅱ.The Journal of Membrane Biology，2007，216(2－3)：93－105.
[10] BlachlyDyson E，Zambronicz E B，Yu W H，et al.Cloning and functional expression in yeast of two human isoforms of the outer mitochondrial membrane channel，the voltagedependent anion channel.The Journal of Biological Chemistry，1993，268(3)：1835－1841.
[11] De Pinto V，Messina A，Lane D J，et al.Voltagedependent anionselective channel(VDAC)in the plasma membrane.FEBS Letters，2010，584(9)：1793－1799.
[12] ShoshanBarmatz V，Hadad N，et al.VDAC/porin is present in sarcoplasmic reticulum from skeletal muscle.FEBS Letters，1996，386(2－3)：205－210.
[13] ShoshanBarmatz V，Zalk R，Gincel D，et al.Subcellular localization of VDAC in mitochondria and ER in the cerebellum.Biochimica et Biophysica Acta，2004，1657(2－3)：105－114.
[14] Bayrhuber M，Meins T，Habeck M，et al.Structure of the human voltagedependent anion channel.Proceedings of the National Academy of Sciences of the United States of America，2008，105(40)：15370－15375.
[15] Hiller S，Garces R G，Malia T J，et al.Solution structure of the integral human membrane protein VDAC1 in detergent micelles.Science，2008，321(5893)：1206－1210.
[16] Ujwal R，Cascio D，Colletier J P，et al.The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating.Proceedings of the National Academy of Sciences of the United States of America，2008，105(46)：17742－17747.
[17] Hiller S，Abramson J，Mannella C，et al.The 3D structures of VDAC represent a native conformation.Trends in Biochemical Sciences，2010，35(9)：514－521.
[18] Geula S，BenHail D，ShoshanBarmatz V．Structurebased analysis of VDAC1：Nterminus location，translocation，channel gating and association with antiapoptotic proteins.Biochemical Journal，2012，444(3)：475－485.
[19] BrahimiHorn M C，BenHail D，Lie M，et al.Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance.Cancer Research，2012，72(8)：2140－2150.
[20] Bai Z，Ye Y，Liang B，et al.Proteomicsbased identification of a group of apoptosisrelated proteins and biomarkers in gastric cancer.International Journal of Oncology，2011，38(2)：375－383.
[21] Simamura E，Shimada H，Ishigaki Y，et al.Bioreductive activation of quinone antitumor drugs by mitochondrial voltagedependent anion channel 1.Anatomical Science International，2008，83(4)：261－266.
[22] Yoo H J，Yun B R，Kwon J H，et al.Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.Experimental & Molecular Medicine，2009，41(2)：102－115.
[23] Bryson J M，Coy P E，Gottlob K，et al.Increased hexokinase activity，of either ectopic or endogenous origin，protects renal epithelial cells against acute oxidantinduced cell death.The Journal of Biological Chemistry，2002，277(13)：11392－11400.
[24] Pedersen P L，Mathupala S，Rempel A，et al.Mitochondrial bound type II hexokinase：Akey player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.Biochimica et Biophysica Acta，2002，1555(1－3)：14－20.
[25] Koppenol W H，Bounds P L，Dang C V．Otto Warburg’s contributions to current concepts of cancer metabolism.Nature Reviews Cancer，2011，11(5)：325－337.
[26] Shimizu S，Tsujimoto Y．Proapoptotic BH3only Bcl2 family members induce cytochrome c release，but not mitochondrial membrane potential loss，and do not directly modulate voltagedependent anion channel activity.Proceedings of the National Academy of Sciences，2000，97(2)：577－582.
[27] Arbel N，ShoshanBarmatz V．Voltagedependent anion channel 1based peptides interact with Bcl2 to prevent antiapoptotic activity.The Journal of Biological Chemistry，2010，285(9)：6053－6062.
[28] ShoshanBarmatz V，BenHail D，Admoni L，et al.The mitochondrial voltagedependent anion channel 1 in tumor cells.Biochimica et Biophysica Acta，2015，1848(10 Pt B)：2547－2575.
[29] ShoshanBarmatz V，BenHail D．VDAC，a multifunctional mitochondrial protein as a pharmacological target.Mitochondrion，2012，12(1)：24－34.
[30] Haridas V，Li X，Mizumachi T，et al.Avicins，a novel plantderived metabolite lowers energy metabolism in tumor cells by targeting the outer mitochondrial membrane.Mitochondrion，2007，7(3)：234－240.
[31] Yang Z，Schumaker L M，Egorin M J，et al.Cisplatin preferentially binds mitochondrial DNA and voltagedependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma：Possible role in apoptosis.Clinical Cancer Research，2006，12(19)：5817－5825.
[32] Lai J C，Tan W，Benimetskaya L，et al.A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.Proceedings of the National Academy of Sciences of the United States of America，2006，103(19)：7494－7499.
[33] Malia T J，Wagner G．NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic BclxL.Biochemistry，2007，46(2)：514－525.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed